| [1] |
Matsuda T, Fujimoto A, Igarashi Y. Colorectal cancer: epidemiology, risk factors, and public health strategies[J]. Digestion, 2025, 106(2): 91-99.
|
| [2] |
Önder AH, Çatli MM. Colorectal cancer treatment commentary review[J]. Eur J Cancer, 2025, 230: 115809.
|
| [3] |
袁晨越, 焦文, 刘湘君, 等. 结直肠癌术后患者舌象特征参数与中医证型分布研究[J]. 中华中医药杂志, 2024, 39(8): 4443-4449.
|
| [4] |
Cai K, Cao XY, Chen F, et al. Xianlian Jiedu Decoction alleviates colorectal cancer by regulating metabolic profiles, intestinal microbiota and metabolites[J]. Phytomedicine, 2024, 128: 155385.
|
| [5] |
Wang Y, Zhao T, Huang C, et al. Effect and mechanism of Banxia Xiexin decoction in colorectal cancer: A network pharmacology approach[J]. Phytomedicine, 2024, 123: 155174.
|
| [6] |
Nong F, Xing S, Cheng W, et al. Zuojin Wan suppresses the progression of colorectal cancer by inhibiting M2 tumor-associated macrophages through JAK2/STAT3 signaling pathway and in vivo and in vitro[J]. Integr Cancer Ther, 2025, 24: 15347354251375951.
|
| [7] |
Sharma A, Zalejski J, Bendre SV, et al. Cholesterol-targeting Wnt-beta-catenin signaling inhibitors for colorectal cancer[J]. Nat Chem Biol, 2025, 21(9): 1376-1386.
|
| [8] |
Voutsadakis IA. CDX2-Suppressed colorectal cancers possess potentially targetable alterations in receptor tyrosine kinases and other colorectal-cancer-associated pathwaysl[J]. Diseases, 2024, 12(10): 234.
|
| [9] |
Shin AE, Sugiura K, Kariuki SW, et al. LIN28B-mediated PI3K/AKT pathway activation promotes metastasis in colorectal cancer models[J]. J Clin Invest, 2025, 135(8): e186035.
|
| [10] |
Sun X, Zhang J, Dong B, et al. Targeting SLITRK4 restrains proliferation and liver metastasis in colorectal cancer via regulating PI3K/AKT/NFkappaB pathway and tumor-associated macrophage[J]. Adv Sci (Weinh), 2025, 12(1): e2400367.
|
| [11] |
Yang S, Ma C, Zhao Y. SPP1(+) macrophages promote colorectal cancer progression by activating JAK2/STAT3 signaling pathway[J]. Sci Rep, 2025, 15(1): 37502.
|
| [12] |
李宏丽, 王梦瑶, 刘洋洋, 等. KHSRP通过激活JAK/STAT信号通路对结直肠癌细胞生物学行为的影响[J]. 吉林大学学报(医学版), 2025, 51(4): 996-1006.
|
| [13] |
Zhang F, Chen X, Qiao C, et al. Exploring the anti-colorectal cancer mechanism of norcantharidin through TRAF5/NF-kappaB pathway regulation and folate-targeted liposomal delivery[J]. Int J Mol Sci, 2025, 26(4): 1450.
|
| [14] |
Gong H, Chen S, Liu S, et al. Overexpressing lipid raft protein STOML2 modulates the tumor microenvironment via NF-kappaB signaling in colorectal cancer[J]. Cell Mol Life Sci, 2024, 81(1): 39.
|
| [15] |
Fan W, Chen Y, Zhou Z, et al. An innovative antibody fusion protein targeting PD-L1, VEGF and TGF-beta with enhanced antitumor efficacies[J]. Int Immunopharmacol, 2024, 130: 111698.
|
| [16] |
Aboushousha T, Osama M, Mohamed M, et al. Significance of CD70, VEGF, and CD90 immunohistochemical expression in colorectal cancer[J]. Asian Pac J Cancer Prev, 2024, 25(10): 3691-3699.
|
| [17] |
崔文文, 张洁, 于边芳, 等. 健脾通络方联合化疗治疗大肠癌术后气虚血瘀型患者临床研究[J]. 山东中医杂志, 2025, 44(5): 539-544.
|
| [18] |
宋琳, 胡灿红, 蒋益兰, 等. 瑞戈非尼联合健脾消癌方对结直肠癌的临床疗效及免疫功能的影响[J]. 湖南中医药大学学报, 2024, 44(7): 1226-1230.
|
| [19] |
李振前, 杨梦春, 刘戎惠, 等. 扶正消癌汤合四君子汤联合卡培他滨治疗晚期结直肠癌临床研究[J]. 陕西中医, 2022, 43(8): 1037-1040.
|
| [20] |
肖国中, 贺秋兰, 刘访, 等. 基于单细胞测序解析四君子汤加减对结直肠癌化疗患者肿瘤微环境的影响[J]. 实用医学杂志, 2023, 39(10): 1296-1304.
|
| [21] |
黄人可, 任建琳, 靖琳, 等. 健脾通络方对结直肠癌细胞侵袭迁移的影响及机制研究[J]. 国际消化病杂志, 2023, 43(1): 39-47.
|
| [22] |
王容容, 王其美, 田雪飞, 等. 健脾消癌方通过PI3K/Akt信号通路抑制结肠癌血管生成的研究[J]. 世界科学技术-中医药现代化, 2022, 24(2): 502-512.
|
| [23] |
焦蕉, 唐麒, 蒋益兰, 等. 健脾消癌方通过lncRNA HOTAIR/JAK2/STAT3信号通路抑制结肠癌细胞株HCT116转移的机制[J]. 中国实验方剂学杂志, 2021, 27(23): 66-71.
|
| [24] |
马漪, 谢琼. 四君子汤对结肠癌肝转移小鼠Wnt/β-catenin信号通路的抑制作用研究[J]. 现代中西医结合杂志, 2021, 30(30): 3322-3327.
|
| [25] |
贾茹, 张影茹, 邵诗芸, 等. 补肾解毒散结方调控JAK/STAT3信号通路抑制大肠癌侵袭转移的研究[J]. 中华中医药杂志, 2020, 35(3): 1433-1436.
|
| [26] |
贾茹, 邵诗芸, 倪中亚, 等. 补肾解毒散结方对脱氧胆酸诱导的TGR5活性及人结肠癌细胞侵袭转移的影响[J]. 上海中医药大学学报, 2020, 34(2): 48-53.
|
| [27] |
Ni M, Zhang Y, Sun Z, et al. Efficacy and safety of Shenbai Granules for recurrent colorectal adenoma: a multicenter randomized controlled trial[J]. Phytomedicine, 2024, 127: 155496.
|
| [28] |
Yuan L, Zhang K, Zhou MM, et al. Erratum: Jiedu Sangen Decoction reverses epithelial-to-mesenchymal transition and inhibits invasion and metastasis of colon cancer via AKT/GSK-3beta signaling pathway: erratum[J]. J Cancer, 2022, 13(15): 3713-3715.
|
| [29] |
黄敏, 范旻旻, 程海波, 等. 参白解毒方基于Wnt/β-catenin信号通路对结直肠癌细胞增殖和迁移的抑制作用[J]. 中华中医药杂志, 2023, 38(2): 789-794.
|
| [30] |
范蓉, 程海波, 许惠琴, 等. 仙连解毒方抑制结肠癌肝转移的作用及机制[J]. 中国医药学报, 2022, 37(9): 5109-5113.
|
| [31] |
谢蓉, 张民权, 李莹, 等. 大黄素药理作用及新剂型研究进展[J]. 中华中医药学刊, 2023, 41(12): 120-125.
|
| [32] |
Dai G, Ding K, Cao Q, et al. Emodin suppresses growth and invasion of colorectal cancer cells by inhibiting VEGFR2[J]. Eur J Pharmacol, 2019, 859: 172525.
|
| [33] |
周利红, 李雁, 隋华, 等. 丹参酮ⅡA调节缺氧诱导因子1α对人结肠癌细胞血管新生的抑制作用[J]. 中华中医药杂志, 2019, 34(3): 947-951.
|
| [34] |
赵景明, 杨铁峥. 乙酰紫草素对结肠癌细胞增殖、凋亡、侵袭及NF-κB通路的影响[J]. 中药材, 2019, 42(9): 2168-2172.
|
| [35] |
张舒, 孟珊珊, 张云鹤, 等. 小檗碱对结肠癌细胞增殖和侵袭的影响及机制[J]. 新乡医学院学报, 2024, 41(11): 1001-1007.
|
| [36] |
周鹏, 吕艳伟, 李静, 等. 吴茱萸碱通过NF-κB-p65信号通路抑制人结肠癌细胞SW480的迁移和侵袭[J]. 第三军医大学学报, 2019, 41(6): 549-555.
|
| [37] |
李铭莹, 林霖, 王岩, 等. 人参皂苷抗肿瘤机制及其纳米药物递送系统的研究进展[J]. 中草药, 2024, 55(2): 688-696.
|
| [38] |
陈曦, 朱玲, 李靖, 等. 积雪草酸对结肠癌细胞迁移与侵袭的抑制作用[J]. 中成药, 2023, 45(11): 3793-3798.
|
| [39] |
边水秀, 皮佩仙, 汪秋颖, 等. 积雪草三萜类有效成分的抗肿瘤作用研究进展[J]. 中药材, 2024, 47(3): 786-791.
|
| [40] |
严玉婷, 任建琳, 王禹喆, 等. 茯苓酸调控GSK3β/β-catenin信号通路抑制结直肠癌细胞增殖迁移的机制研究[J]. 国际消化病杂志, 2025, 45(3): 165-170.
|
| [41] |
吴文宇, 杨柱, 龙奉玺, 等. 木香烃内酯通过PI3K/AKT信号通路调控结直肠癌细胞增殖、凋亡、侵袭和迁移[J]. 中药材, 2020, 43(2): 429-435.
|
| [42] |
陈林俊, 陈文斌. 岩大戟内酯B通过阻断PI3K/Akt/NF-κB通路抑制结肠癌细胞的增殖和转移[J]. 中国临床药理学与治疗学, 2021, 26(3): 250-257.
|
| [43] |
李红, 董玮, 侯杰, 等. 黄芩苷调控PI3K/AKT/GSK-3β途径对人结肠癌细胞生物学行为的影响[J]. 中华中医药学刊, 2021, 39(3): 241-245, 后插21-后插22.
|
| [44] |
吕琳, 李静. 槲皮素调控JAK2/STAT3对直肠癌细胞生物活性的影响[J]. 中国现代普通外科进展, 2023, 26(1): 7-12.
|
| [45] |
王超, 陈尚, 闫立凯, 等. 白藜芦醇对人结肠癌细胞上皮间质转化的抑制作用[J]. 实用药物与临床, 2020, 23(1): 25-29.
|
| [46] |
Chidananda C, Thakur G, Datta D et al. A comprehensive review of alkaloids in cancer therapy: focusing on molecular mechanisms and synergistic potential of piperine in colorectal cancer[J]. 3 Biotech, 2025, 15(11): 403.
|
| [47] |
裴永彬, 王桂琦, 李卫, 等. 姜黄素对结直肠癌小鼠肿瘤生长的抑制作用及其PTEN/PI3K/Akt信号通路机制[J]. 吉林大学学报: 医学版, 2021, 47(1): 145-151.
|
| [48] |
陈佳, 夏琪, 李祎楠, 等. 华蟾素毒基通过JAK2/STAT3途径对人结肠癌细胞增殖, 迁移及侵袭的影响[J]. 中国临床药理学杂志, 2024, 40(12): 1764-1768.
|